Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitis

J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1346-8. doi: 10.1136/jnnp.2003.024653.

Abstract

Idiopathic hypertrophic chronic pachymeningitis (IHCP) is characterised by inflammatory fibrotic thickening of the dura mater. Long term management is controversial. A 28 year old man with craniospinal IHCP and prominent lymphocytic meningitis is reported. Cerebrospinal fluid and histological examination suggested a CD4+ T cell driven process and B cell stimulation. After surgical, tuberculostatic, and immunosuppressive treatment failed to control the progressive meningeal hypertrophy, causing severe headache and neurological disability, the disease process eventually abated with intraventricular cytarabine treatment.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Chronic Disease
  • Cytarabine / administration & dosage
  • Cytarabine / therapeutic use*
  • Disease Progression
  • Dura Mater / pathology
  • Headache / etiology
  • Humans
  • Hypertrophy
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Inflammation
  • Injections, Intraventricular
  • Male
  • Meningitis / drug therapy*
  • Meningitis / pathology
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Cytarabine